Carbidopa and Levodopa Orally Disintegrating Tablets and Ibritumomab Tiuxetan
Determining the interaction of Carbidopa and Levodopa Orally Disintegrating Tablets and Ibritumomab Tiuxetan and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and Levodopa Orally Disintegrating Tablets-Ibrutinib
- Carbidopa and Levodopa Orally Disintegrating Tablets-Ibrutinib Capsules
- Carbidopa and Levodopa Orally Disintegrating Tablets-Ibrutinib Tablets
- Carbidopa and Levodopa Orally Disintegrating Tablets-Ibu
- Carbidopa and Levodopa Orally Disintegrating Tablets-IBU Tablets
- Carbidopa and Levodopa Orally Disintegrating Tablets-Ibu-2
- Ibritumomab Tiuxetan-Carbidopa and levodopa Route Not Applicable
- Ibritumomab Tiuxetan-Carbidopa and Levodopa Tablets
- Ibritumomab Tiuxetan-Carbidopa Tablets
- Ibritumomab Tiuxetan-Carbidopa, entacapone, and levodopa
- Ibritumomab Tiuxetan-Carbidopa, Levodopa and Entacapone
- Ibritumomab Tiuxetan-Carbidopa, Levodopa and Entacapone Tablets